Treatment for severe acute respiratory illness associated with coronavirus
US11844792B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Inventor
Key dates
| Filing date | Jul 9, 2021 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Jul 9, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for identifying a patient having a respiratory illness and administering to the patient a combination of an anti-inflammatory agent and a leukotriene inhibitor. The method may include treating respiratory illness associated with a coronavirus, and may it may further include reducing or preventing an inflammatory response or cytokine storm for those patients without impairing their immune response against the underlying pathogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.